1. Home
  2. XELB vs APVO Comparison

XELB vs APVO Comparison

Compare XELB & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xcel Brands Inc.

XELB

Xcel Brands Inc.

HOLD

Current Price

$1.23

Market Cap

8.4M

Sector

Miscellaneous

ML Signal

HOLD

Logo Aptevo Therapeutics Inc.

APVO

Aptevo Therapeutics Inc.

N/A

Current Price

$4.39

Market Cap

8.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
XELB
APVO
Founded
2011
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.4M
8.3M
IPO Year
2011
2023

Fundamental Metrics

Financial Performance
Metric
XELB
APVO
Price
$1.23
$4.39
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
61.3K
35.8K
Earning Date
04-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
48.37
0.13
EPS
N/A
N/A
Revenue
N/A
$3,114,000.00
Revenue This Year
$102.11
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.74
$0.50
52 Week High
$2.66
$10.70

Technical Indicators

Market Signals
Indicator
XELB
APVO
Relative Strength Index (RSI) 33.64 45.46
Support Level $1.00 $3.81
Resistance Level $1.67 $4.84
Average True Range (ATR) 0.14 0.31
MACD -0.01 0.01
Stochastic Oscillator 9.30 55.67

Price Performance

Historical Comparison
XELB
APVO

About XELB Xcel Brands Inc.

Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain designs, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.

About APVO Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

Share on Social Networks: